Table 3.
AIDS-related | Non-AIDS-related | ||||||
---|---|---|---|---|---|---|---|
Characteristics | Follow-up time (32 361 person-years) | Deaths, n = 183 | asHR (95% CI) | P value | Deaths, n = 84 | asHR (95% CI) | P value |
Sex | |||||||
Male | 16 482 | 95 | – | – | 51 | ||
Female | 15 879 | 88 | – | – | 33 | 0.75 (0.48–1.17) | 0.207 |
Current age (years)a | <0.001 | 0.002 | |||||
<1 | 173 | 18 | 5.09 (2.80–9.23) | <0.001 | 7 | 3.79 (1.62–8.84) | 0.002 |
1–4 | 3894 | 64 | 1.82 (1.24–2.67) | 0.002 | 18 | 1.15 (0.63–2.11) | 0.647 |
5–9 | 10 031 | 46 | 1.00 | 23 | 1.00 | ||
10–14 | 10 982 | 29 | 0.89 (0.56–1.41) | 0.609 | 14 | 0.67 (0.34–1.31) | 0.244 |
15–19 | 6201 | 20 | 1.62 (0.92–2.84) | 0.094 | 20 | 2.03 (1.06–3.91) | 0.034 |
20–24 | 10 788 | 6 | 2.17 (0.88–5.34) | 0.093 | 2 | 1.04 (0.20–5.51) | 0.959 |
Current CD4+ cell count (cells/μl)a | <0.001 | 0.005 | |||||
<200 | 1629 | 116 | 1.00 | 23 | 1.00 | ||
200–349 | 1478 | 11 | 0.20 (0.10–0.38) | <0.001 | 13 | 1.27 (0.62–2.61) | 0.519 |
350–499 | 7223 | 20 | 0.15 (0.09–0.26) | <0.001 | 19 | 0.59 (0.29–1.19) | 0.141 |
≥500 | 17 628 | 4 | 0.02 (0.01–0.05) | <0.001 | 20 | 0.35 (0.17–0.73) | 0.005 |
Missing | 4403 | 32 | 9 | ||||
Current weight-for- age z-scorea | 0.029 | <0.001 | |||||
<−3 | 4327 | 127 | 1.00 | 41 | 1.00 | ||
≤−3 to <−2 | 6005 | 17 | 0.23 (0.14–0.39) | <0.001 | 11 | 0.36 (0.18–0.73) | 0.005 |
≥−2 | 17 636 | 20 | 0.14 (0.08–0.24) | <0.001 | 21 | 0.29 (0.17–0.52) | <0.001 |
Missing | 4392 | 19 | 11 | ||||
History of AIDS diagnosisa | |||||||
No | 14 796 | 14 | 1.00 | 10 | 1.00 | ||
Yes | 17 565 | 169 | 5.35 (3.04–9.42) | <0.001 | 74 | 4.67 (2.35–9.25) | <0.001 |
Currently on second-line cARTa | |||||||
No | 27 453 | 158 | 1.00 | 67 | 1.00 | ||
Yes | 4908 | 25 | 1.41 (0.87.2.30) | 0.163 | 17 | 1.75 (1.00–3.09) | 0.051 |
Facility setting | 0.021 | 0.145 | |||||
Urban | 19 909 | 136 | 1.00 | 46 | 1.00 | ||
Mostly urban | 10 436 | 37 | 0.74 (0.52–1.07) | 0.106 | 27 | 1.43 (0.88–2.32) | 0.146 |
Mostly rural | 2016 | 10 | 0.43 (0.22–0.85) | 0.015 | 11 | 1.73 (0.90–3.31) | 0.101 |
Year of first cART | <0.001 | 0.101 | |||||
<2008 | 17 409 | 48 | 1.00 | 35 | 1.00 | ||
2008–1010 | 8898 | 96 | 1.49 (1.02–2.18) | 0.041 | 36 | 1.42 (0.80–2.50) | 0.230 |
2011–2013 | 4696 | 35 | 0.90 (0.56–1.45) | 0.665 | 11 | 0.77 (0.37–1.60) | 0.479 |
2014–2017 | 1358 | 4 | 0.26 (0.09–0.76) | 0.014 | 2 | 0.36 (0.08–1.62) | 0.182 |
Deaths due to non-AIDS-related underlying causes (n = 84) and those for which causes were unknown or not reviewed (n = 45) were competing events for deaths due to AIDS-related underlying causes (n = 183). Similarly, deaths due to AIDS-related underlying causes and those for which causes were unknown or not reviewed were competing events for death due to non-AIDS-related causes. 95% CI, 95% confidence interval; asHR, adjusted sub distribution hazard ratio; cART, combination antiretroviral therapy of three or more antiretrovirals.
Current age, CD4+ cell count, weight-for-age z-score, second-line, and AIDS were considered time-dependent variables.